Workflow
K12 Wins 2025 Tech & Learning Award for Excellence in Social Learning
Globenewswire· 2025-10-01 12:00
Company honored for their virtual campus K12 ZoneRESTON, VA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- K12, a national leader in online learning for 25 years, has been named a winner of the Tech & Learning Awards of Excellence for its innovative virtual campus, K12 Zone. A key part of the K12 experience, K12 Zone creates community through virtual field trips, clubs, competitions, and other activities that bring campus life online. K12 serves more than three million students nationwide, helping students access high ...
Brooge Energy Limited Announces Results of Extraordinary Meeting of Shareholders
Globenewswire· 2025-10-01 12:00
DUBAI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Brooge Energy Limited (“BEL” or the “Company”), a Cayman Islands-based infrastructure provider, which is engaged in Clean Petroleum Products and Biofuels and Crude Oil storage and related services, hereby announces the results of the Company’s extraordinary general meeting of the shareholders (the “Meeting”) held on 30 September 2025. The record date for determining shareholder eligibility to vote at the Meeting was market close on Wednesday 10 September 2025 (the " ...
Apollo Names Jaycee Pribulsky as Partner and Chief Sustainability Officer
Globenewswire· 2025-10-01 12:00
Pribulsky succeeds Dave Stangis, who will transition to a senior advisor role in 2026NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE: APO) today announced that Jaycee Pribulsky has been named Partner and Chief Sustainability Officer (CSO), effective October 1. Pribulsky will lead Apollo’s established sustainability strategy, which aims to strengthen long-term value creation and enhance risk management across the firm’s integrated investment platform. Stangis, who has served ...
The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference
Globenewswire· 2025-10-01 12:00
CERRITOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference, on October 8, 2025, including a presentation at 11:00am ET. Interested parties can access a webcast of the presentation by registering at the link listed on the Investor Relati ...
EagleNXT Partners with UAVSICS to Expand Drone Solutions in Chile
Globenewswire· 2025-10-01 12:00
Company continues to deploy sales and service capability in expanding Latin America region WICHITA, Kan., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is proud to announce UAVSICS as the official distributor of EagleNXT drones in Chile, strengthening its leadership in the region and expanding access to cutting-edge UAV technology. Based in one of the key financial a ...
Greif Appoints Dennis Hoffman as General Counsel
Globenewswire· 2025-10-01 12:00
DELAWARE, Ohio, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in performance packaging products and services, announced today that Dennis Hoffman has been appointed Senior Vice President, General Counsel and Corporate Secretary. Hoffman succeeds Gary Martz, who will retire from Greif on November 30, 2025, as previously announced. Hoffman brings deep experience across corporate law, governance, mergers and acquisitions, joint ventures, and environmental compliance. He has ...
NOVAGOLD Files Third Quarter 2025 Report
Globenewswire· 2025-10-01 12:00
Successfully completed the transformative $1 billion acquisition1 of Barrick Mining Corporation’s (“Barrick Mining”) 50 percent interest in Donlin Gold on June 3, 2025, where NOVAGOLD increased its stake in Donlin Gold LLC to 60 percent, acquiring an additional 10 percent interest for $200 million, while funds managed by Paulson Advisers LLC (“Paulson”) secured a 40 percent interest for $800 million.Announced the full exercise of the underwriters’ option in the public offering on June 5, 2025, raising an ad ...
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
Globenewswire· 2025-10-01 12:00
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for oral presentation at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress, taking place October 7-10, 2025. The presentation will introduce the Company’s novel SyNTase gene editing technology and highlight its application in single-dos ...
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
Globenewswire· 2025-10-01 12:00
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced that the U.S. Food and Drug Administration (“FDA”) has issued a Complete Response Letter (“CRL”) relating to the New Drug Application (“NDA”) for CUTX-101 (copper histidinate), intended to treat Menkes disease in pediatric patients. In December 2023, Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company ...
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments
Globenewswire· 2025-10-01 12:00
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitive Asset Purchase Agreement (the “Agreement”) for the sale of its Abbreviated New Drug Application (ANDA #217858) for Ketamine Hydrochloride Injection USP to a well-established global pharmaceutical company specializing in steri ...